The Durham Investor That Treats Venture Capital Like a Clinical Program

Pappas Capital has spent three decades turning laboratory risk into investable milestones. Its edge is less about chasing crowded hubs than combining drug-development judgment, company-building work and patient capital from a base in Research Triangle Park.